subject: UNII:249EAP69MT

object_name: cancer


subject: UNII:249EAP69MT

subject_name: COFETUZUMAB PELIDOTIN

object_name: neoplasm

tested_intervention: unsure


subject: UMLS:C4085991

object_name: non-small cell lung carcinoma


subject: UMLS:C4085991


subject: UMLS:C4085991


subject: CHEBI:64312

subject_name: Memantine

object_name: Post-Operative Pain

tested_intervention: yes


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: small intestinal neuroendocrine tumor G1


subject: CHEBI:23965

subject_name: estradiol

object_name: Uses contraception (finding)


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PUBCHEM.COMPOUND:13505135

subject_name: Nomegestrol acetate


subject: UNII:E6CKI5C54O

object_name: schizophrenia


subject: UNII:XXV4WFG08S


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:11654566

object_name: non-Hodgkin lymphoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: thyroid disease


subject: CHEBI:149504

object_name: impaired renal function disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:151315

subject_name: Heparin

object_name: Refractory angina


subject: CHEBI:151315

object_name: Angina pectoris


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Brainstem death


subject: PUBCHEM.COMPOUND:155543961

object_name: Brain Death


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1145201

object_name: pancreatic neoplasm


subject: UMLS:C1145201

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1145201

object_name: malignant pancreatic neoplasm


subject: UMLS:C1145201

object_name: pancreatic adenocarcinoma


subject: UMLS:C1145201

object_name: esophageal adenocarcinoma


subject: UMLS:C1145201

object_name: lung adenocarcinoma


subject: UMLS:C1145201

object_name: cervical adenocarcinoma


subject: UMLS:C1145201

object_name: adenocarcinoma


subject: UMLS:C1145201

object_name: bile duct adenocarcinoma


subject: UMLS:C1145201

object_name: gastric adenocarcinoma


subject: UMLS:C1145201

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:7931


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C2000963

object_name: Staphylococcal bacteraemia


subject: CHEBI:36791

subject_name: Escitalopram

object_name: dyspepsia


subject: CHEBI:36791

object_name: Dyspepsia, CTCAE


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Post-Operative Pain


subject: CHEBI:233446

subject_name: suzetrigine


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: neurofibromatosis 1


subject: PUBCHEM.COMPOUND:5281767

object_name: neurofibromatosis type 1


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: Ischemic stroke


subject: CHEBI:135928

subject_name: Doripenem

object_name: Febrile Neutropenia


subject: CHEBI:135928

object_name: Febrile Neutropenia, CTCAE


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells

object_name: osteoarthritis, knee


subject: CHEBI:188219

object_name: nicotine dependence


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Plasma cell leukemia in remission


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: alcoholic hepatitis


subject: CHEBI:6770

subject_name: MEROPENEM


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Angina pectoris


subject: CHEBI:2668

subject_name: Amlodipine

object_name: inherited lipid metabolism disorder


subject: CHEBI:2668

object_name: Dyslipidemia


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:820NH671E6

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:820NH671E6

object_name: Refractory Primary Central Nervous System Neoplasm


subject: UNII:820NH671E6

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: UNII:820NH671E6

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: Manic Disorder


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Plasma cell myeloma refractory


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: HIV-1 infection


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Alzheimer disease


subject: UMLS:C1310928

object_name: end stage renal failure


subject: UMLS:C1310928

object_name: Chronic uremia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: head and neck neoplasm


subject: CHEBI:7496

object_name: adenoid cystic carcinoma


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: Diabetic foot ulcer


subject: CHEBI:194425

subject_name: Lobaplatin

object_name: esophageal cancer


subject: CHEBI:194425

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:194425

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:192744


subject: CHEBI:192744


subject: UNII:7K28NB895L

subject_name: Belzutifan


subject: UNII:7K28NB895L


subject: UNII:7K28NB895L

object_name: kidney failure


subject: CHEBI:6456

subject_name: Lidocaine

object_name: common cold


subject: CHEBI:6456

object_name: non-allergic rhinitis


subject: CHEBI:61080

subject_name: Romidepsin

object_name: colorectal cancer


subject: CHEBI:61080

object_name: colorectal carcinoma


subject: CHEBI:61080

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: hypotension


subject: CHEBI:3215

object_name: Hypotension, CTCAE


subject: CHEBI:3215

object_name: Pregnant


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: chronic rhinosinusitis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:8871

subject_name: Risperidone

object_name: delirium


subject: CHEBI:8871

object_name: Delirium, CTCAE


subject: CHEBI:8871

object_name: Agitation, CTCAE 3.0


subject: CHEBI:8871

object_name: Agitation


subject: CHEBI:8871

object_name: Agitation, CTCAE 5.0


subject: CHEBI:9654

subject_name: Trazodone


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: STAPH AUREUS METHICILLIN RESISTANT BACTEREMIA


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: cervical carcinoma


subject: UMLS:C0360363

subject_name: Azole antifungal

object_name: Mycoses


subject: UMLS:C3536759

subject_name: Azole Antifungal [EPC]


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Recurrent ovarian cancer


subject: CHEBI:114785

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Ovarian cancer stage IV


subject: UMLS:C0244460

object_name: Muscle spasm


subject: UMLS:C0244460

object_name: Muscle Cramp, CTCAE


subject: UMLS:C0244460

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C0244460

object_name: amyotrophic lateral sclerosis


subject: UNII:S866O45PIG

subject_name: Beractant

object_name: Poor peripheral perfusion


subject: UNII:KE3U2023NP

subject_name: Poractant alfa


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Anticoagulants and Bleeding Disorders


subject: CHEBI:68579

object_name: stroke disorder


subject: CHEBI:68579

object_name: cerebrovascular disorder


subject: CHEBI:68579

object_name: Stroke (heart beat)


subject: CHEBI:68579

object_name: Stroke, CTCAE


subject: UMLS:C5667024

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:63631

subject_name: Topiramate

object_name: borderline personality disorder


subject: CHEBI:7772

subject_name: omeprazole

object_name: congenital dyserythropoietic anemia type 1


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: non-small cell lung carcinoma


subject: CHEBI:50162

object_name: esophageal adenocarcinoma


subject: CHEBI:50162

object_name: lung adenocarcinoma


subject: CHEBI:50162

object_name: cervical adenocarcinoma


subject: CHEBI:50162

object_name: adenocarcinoma


subject: CHEBI:50162

object_name: bile duct adenocarcinoma


subject: CHEBI:50162

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEBI:6931

subject_name: Midazolam

object_name: Medication interaction potentiation


subject: PUBCHEM.COMPOUND:496847

subject_name: vamorolone


subject: PUBCHEM.COMPOUND:2269

object_name: sinusitis


subject: PUBCHEM.COMPOUND:2269

object_name: Sinusitis, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: myopathy


subject: CHEBI:39548

object_name: muscle tissue disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:8707

subject_name: Quetiapine

object_name: alcohol abuse


subject: CHEBI:63631

object_name: bipolar disorder


subject: UMLS:C3886790

object_name: chronic hepatitis C virus infection


subject: CHEBI:78543

subject_name: Ponatinib


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Advanced cancer


subject: UMLS:C4287682

subject_name: c-Met Inhibitor HS-10241


subject: MESH:C000726227

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:3080587

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:3080587

object_name: head and neck cancer


subject: CHEBI:73610

subject_name: Met-Ala


subject: CHEBI:73610


subject: CHEBI:73610


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:90325


subject: CHEBI:6810

subject_name: Metandienone


subject: CHEBI:6810


subject: CHEBI:6810


subject: CHEBI:474859

subject_name: maleic anhydride


subject: CHEBI:474859


subject: CHEBI:474859


subject: PR:000033943

subject_name: class II histocompatibility antigen, M alpha chain


subject: PR:000033943


subject: PR:000033943


subject: UniProtKB:P28078

subject_name: DMA_MOUSE Class II histocompatibility antigen, M alpha chain (sprot)


subject: UniProtKB:P28078


subject: UniProtKB:P28078


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Childhood Neuroblastoma


subject: UNII:MRL3739G66

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate

object_name: Infantile cataract


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:135686

subject_name: Alvimopan

object_name: Ventral hernia


subject: UMLS:C5854517

subject_name: Anti-DDR1 Monoclonal Antibody PRTH-101

object_name: non-small cell lung carcinoma


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: acute myocardial infarction


subject: UNII:WGD229O42W

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Acute Stroke


subject: CHEBI:39548

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:38545


subject: CHEBI:49956

subject_name: Xenon

object_name: coronary artery disorder


subject: CHEBI:49956

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:135449332

object_name: acute myeloid leukemia


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: plasma cell myeloma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Plasma cell myeloma refractory


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: primary antiphospholipid syndrome


subject: CHEBI:37144

object_name: EXCESS LMW-DNA


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Blood Clot


subject: MESH:D006495

object_name: thrombosis


subject: MESH:D006495

object_name: Thrombosis of blood vessel


subject: MESH:D006495

object_name: cancer


subject: MESH:D006495

object_name: neoplasm


subject: MESH:D006495

object_name: Pulmonary Embolism Related to COVID-19


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:2663

subject_name: Amiodarone


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:6931

subject_name: Midazolam

object_name: Emergence Delirium


subject: UMLS:C0721973

subject_name: Nasal Saline


subject: UMLS:C2347570

object_name: Childhood Breast Carcinoma


subject: UMLS:C2347570

object_name: breast carcinoma


subject: UMLS:C2347570

object_name: breast cancer


subject: CHEBI:42941

object_name: Klatskin Tumor


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: vasomotor rhinitis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: diffuse large B-cell lymphoma


subject: CHEBI:71200

subject_name: Tofacitinib


subject: UMLS:C0796406

subject_name: OncoVax-PR

object_name: prostate carcinoma


subject: UMLS:C0796406

object_name: prostate cancer


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C3896771


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Glue ear


subject: CHEBI:6375

object_name: serous otitis media


subject: CHEBI:6375

object_name: Otitis media with effusion


subject: CHEBI:3240

subject_name: Butoconazole

object_name: vulvovaginal candidiasis


subject: CHEBI:36704

subject_name: Imiquimod

object_name: invasive carcinoma


subject: CHEBI:36704

object_name: Basal cell carcinoma of skin, site unspecified


subject: CHEBI:36704

object_name: skin neoplasm


subject: CHEBI:36704

object_name: skin cancer


subject: UMLS:C0876064

subject_name: Lantus

object_name: diabetic retinopathy


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:27563

subject_name: arsenic atom

object_name: acute promyelocytic leukemia


subject: CHEBI:47217

subject_name: arsane


subject: CHEBI:35828


subject: UNII:CR743OME9E

object_name: aneurysm


subject: UMLS:C1537063

subject_name: tetraspan

object_name: coronary artery disorder


subject: UMLS:C1874000

subject_name: Acetated Ringer's Solution


subject: CHEBI:22678

subject_name: avenic acid A

object_name: bacterial infectious disease


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: GTOPDB:13344

subject_name: raxibacumab


subject: UNII:794PGL549S

subject_name: Raxibacumab


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Failed induction of labor


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: cytokine release syndrome


subject: PUBCHEM.COMPOUND:2735

object_name: Cytokine storm


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: obstructive sleep apnea syndrome


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Calcinosis cutis


subject: CHEBI:16480

object_name: Raynaud disease


subject: CHEBI:16480

object_name: scleroderma, familial progressive


subject: CHEBI:16480

object_name: CREST syndrome


subject: CHEBI:233331

subject_name: Elamipretide

object_name: age-related macular degeneration


subject: UMLS:C4279623


subject: UMLS:C4733601

object_name: non-small cell lung carcinoma


subject: CHEBI:32599

object_name: renal hypomagnesemia 3


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: iron metabolism disease


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:3286

subject_name: Cabergoline

object_name: female infertility


subject: CHEBI:31859

subject_name: Modafinil

object_name: Cognitive impairment


subject: CHEBI:7726

subject_name: octreotide

object_name: Periampullary carcinoma resectable


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: small cell lung carcinoma


subject: MESH:C000634404

object_name: kidney failure


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: traumatic encephalopathy


subject: CHEBI:73604

object_name: traumatic brain injury


subject: UMLS:C2830151

object_name: hepatitis C


subject: UMLS:C2830151

object_name: Chronic hepatitis


subject: CHEBI:31401

subject_name: Cilostazol

object_name: coronary artery disorder


subject: CHEBI:31401

object_name: coronary atherosclerosis


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: complication


subject: CHEBI:42588

subject_name: Fenretinide

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:42588

object_name: Childhood Neuroblastoma


subject: CHEBI:42588

object_name: neuroblastoma


subject: CHEBI:520985

subject_name: Almotriptan

object_name: migraine


subject: CHEBI:520985

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: malaria


subject: UNII:VT3A7NA96K


subject: UMLS:C1327972

subject_name: Fowlpox-PSA-TRICOM Vaccine

object_name: prostate carcinoma


subject: UMLS:C1327972

object_name: prostate cancer


subject: UMLS:C0723892

subject_name: Tricom brand of acetaminophen / chlorpheniramine / pseudoephedrine


subject: UMLS:C0723892


subject: UMLS:C1523982

subject_name: TRIad of COstimulatory Molecules (B7-1, ICAM-1, LFA-3)


subject: UMLS:C1523982


subject: UMLS:C4282329

subject_name: Prostvac-V


subject: UMLS:C4282329


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: cancer


subject: CHEBI:85974

object_name: neoplasm


subject: CHEBI:85974

object_name: pulmonary embolism


subject: CHEBI:85974

object_name: Deep venous thrombosis


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: UMLS:C3831201

subject_name: Carbon C 14 Oxaliplatin

object_name: colon adenocarcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C4721525

subject_name: Therapeutic Estradiol

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C4721525

object_name: Advanced Triple-Negative Breast Carcinoma


subject: UMLS:C4721525

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4721525

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4721525

object_name: Breast cancer recurrent


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Sepsis


subject: CHEBI:6770

object_name: Sepsis, CTCAE


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:84040

object_name: peripheral vascular disease


subject: CHEBI:84040

object_name: peripheral arterial disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: end stage renal failure


subject: CHEBI:73604

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea

object_name: permanent neonatal diabetes mellitus


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: Constipation


subject: UMLS:C1321801

object_name: Constipation, CTCAE


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C0225326


subject: UMLS:C1831847

subject_name: Live Freeze-Dried Lactic Acid Bacteria Probiotic

object_name: Malignant Solid Neoplasm


subject: UNII:0HG7S0S581

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:46783403

object_name: cancer


subject: UMLS:C5962750

subject_name: SMARCA2 Degrader PRT7732

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5962750

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5962750


subject: UMLS:C5962750

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5962750

object_name: gastric squamous cell carcinoma


subject: UMLS:C5962750

object_name: non-small cell lung carcinoma


subject: UMLS:C5962750

object_name: esophageal adenocarcinoma


subject: UMLS:C5962750

object_name: gastric adenocarcinoma


subject: UMLS:C0525959

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C0525959

object_name: pulmonary hypertension


subject: UMLS:C0525959

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C0525959

object_name: pulmonary arterial hypertension


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:23965


subject: PUBCHEM.COMPOUND:156498110

subject_name: BLEXIMENIB

object_name: acute myeloid leukemia


subject: UNII:DCN5WEN78T


subject: CHEBI:50692

subject_name: Mifepristone

object_name: leiomyoma


subject: CHEBI:132082

subject_name: Entinostat

object_name: Metastatic Uveal Melanoma


subject: CHEBI:142708

object_name: gram-negative bacterial infections


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: Thrombocytopenia, severe


subject: PR:000001366


subject: UMLS:C0537668

subject_name: Neumega


subject: PUBCHEM.COMPOUND:11557104

subject_name: PIMAVANSERIN TARTRATE

object_name: Parkinson's disease psychosis


subject: CHEBI:133017

subject_name: Pimavanserin


subject: UMLS:C1722268

subject_name: ACP 103


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: bacterial infectious disease


subject: UNII:1W5N8SZD9A

subject_name: Glufosfamide

object_name: lung cancer


subject: UNII:1W5N8SZD9A

object_name: lung neoplasm


subject: UNII:1W5N8SZD9A

object_name: lung carcinoma


subject: UNII:HM5641GA6F

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0537668


subject: UMLS:C5555006

object_name: metastatic colorectal cancer


subject: UMLS:C5203926

subject_name: EZH2 Inhibitor SHR2554


subject: UMLS:C2362561

subject_name: Gluten

object_name: celiac disease


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: UMLS:C2984197

subject_name: Ciclopirox Olamine Oral

object_name: adverse effect of drugs and medicaments in therapeutic use


subject: CHEBI:36796

subject_name: duloxetine

object_name: temporomandibular joint disorder


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: colon carcinoma


subject: UNII:M89N0Q7EQR

object_name: colorectal cancer


subject: UNII:M89N0Q7EQR

object_name: colon cancer


subject: UNII:M89N0Q7EQR

object_name: rectal carcinoma


subject: UNII:M89N0Q7EQR

object_name: rectal cancer


subject: UNII:M89N0Q7EQR

object_name: Childhood Rectal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stomach cancer


subject: UNII:M89N0Q7EQR

object_name: gastric cancer


subject: UNII:M89N0Q7EQR

object_name: pancreatic neoplasm


subject: UNII:M89N0Q7EQR

object_name: exocrine pancreatic carcinoma


subject: UNII:M89N0Q7EQR

object_name: malignant pancreatic neoplasm


subject: UNII:M89N0Q7EQR

object_name: digestive system cancer


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C4329339

object_name: HER2 positive breast carcinoma


subject: CHEBI:137238

subject_name: Ala-Arg

object_name: Traumatic Wound


subject: CHEBI:137238

object_name: Other ulcers, wounds and skin problems


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:135402

subject_name: Promestriene

object_name: Childhood Breast Carcinoma


subject: CHEBI:135402

object_name: breast carcinoma


subject: CHEBI:135402

object_name: breast cancer


subject: CHEBI:135402

object_name: Vaginal Atrophy


subject: CHEBI:135402

object_name: atrophic vulva


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastatic non-small cell lung cancer


subject: UNII:9TDN93L9FN

object_name: osteoporosis


subject: UNII:9TDN93L9FN

object_name: Encounter due to family history of osteoporosis


subject: UNII:9TDN93L9FN

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:9TDN93L9FN

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:9TDN93L9FN

object_name: Osteopenia


subject: CHEMBL.COMPOUND:CHEMBL4802176


subject: CHEMBL.COMPOUND:CHEMBL4802176


subject: CHEMBL.COMPOUND:CHEMBL4802176


subject: CHEMBL.COMPOUND:CHEMBL4802176


subject: CHEMBL.COMPOUND:CHEMBL4802176


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Glabellar frown lines


subject: UNII:0A6JH35GMQ

subject_name: prabotulinumtoxinA


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:175901

object_name: non-Hodgkin lymphoma


subject: CHEBI:131165


subject: CHEBI:131165


subject: CHEBI:131165

object_name: Hodgkin Disease


subject: CHEBI:131165

object_name: neoplasm


subject: UMLS:C2703183


subject: UMLS:C2703183


subject: UMLS:C2703183


subject: UMLS:C2703183


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Ovarian cancer stage III


subject: UNII:28X28X9OKV

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:6DPK7O4PR7

subject_name: Selatogrel

object_name: acute myocardial infarction


subject: UNII:6DPK7O4PR7

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: UNII:D733ET3F9O

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: UNII:D733ET3F9O

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UNII:D733ET3F9O

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: CHEBI:4026


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Mechanical ventilation finding


subject: CHEBI:28939

object_name: ventilator-associated pneumonia


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological


subject: UMLS:C3540708


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: sexual disorder


subject: PUBCHEM.COMPOUND:5470

object_name: physiological sexual disorder


subject: CHEBI:11909

subject_name: Sepranolone

object_name: post-traumatic stress disorder


subject: CHEBI:50169

subject_name: Brexanolone


subject: UMLS:C5555467

subject_name: Latozinemab

object_name: Pick Complex


subject: UMLS:C5555467

object_name: frontotemporal dementia


subject: UMLS:C5555467

object_name: Pick disease


subject: UMLS:C5705654


subject: UMLS:C5705654


subject: UMLS:C5705654


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Alzheimer disease


subject: CHEBI:94534

subject_name: olanzapine


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: breast neoplasm


subject: CHEBI:91400

subject_name: Afatinib


subject: DRUGBANK:DB11058

subject_name: Petrolatum

object_name: radiodermatitis


subject: UMLS:C4087015


subject: UNII:Z0O4TJ588O

subject_name: Posiphen

object_name: Parkinson disease


subject: UMLS:C5707962

subject_name: Buntanetap


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: High risk of


subject: CHEBI:4026

object_name: High risk


subject: CHEBI:4026

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: CHEBI:4026

object_name: High Risk Acute Leukemia


subject: CHEBI:4026

object_name: International Prognostic Index High Risk Group


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:9K8GNJ2874

subject_name: Naxitamab


subject: UNII:9K8GNJ2874


subject: UNII:9K8GNJ2874


subject: UNII:9K8GNJ2874


subject: UNII:9K8GNJ2874


subject: UMLS:C4054758

subject_name: naxitamab


subject: UMLS:C4054758


subject: UMLS:C4054758


subject: UMLS:C4054758


subject: UMLS:C4054758


subject: UNII:T930SOU82P

object_name: schizophrenia


subject: UNII:T930SOU82P

object_name: cognitive disorder


subject: UNII:T930SOU82P


subject: UMLS:C4687480

subject_name: Nanoparticle Paclitaxel Ointment SOR007

object_name: actinic keratosis


subject: UMLS:C5908068

subject_name: MEK Inhibitor IMM-6-415

object_name: melanoma, cutaneous malignant, susceptibility to, 1


subject: UMLS:C5908068

object_name: skin melanoma


subject: UMLS:C5908068

object_name: susceptibility to familial cutaneous melanoma


subject: UMLS:C5908068

object_name: non-small cell lung carcinoma


subject: UMLS:C5908068

object_name: pancreatic adenocarcinoma


subject: UMLS:C2346810

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2346810

object_name: clear cell renal carcinoma


subject: UMLS:C2346810

object_name: renal cell adenocarcinoma


subject: UMLS:C2346810

object_name: renal cell carcinoma


subject: PR:000012530

subject_name: astrocytic phosphoprotein PEA-15

object_name: Postoperative Complications


subject: PR:000012530

object_name: Encounter due to care involving use of rehabilitation procedures


subject: UMLS:C2698187

subject_name: Astrocytic Phosphoprotein PEA-15


subject: UMLS:C2698187


subject: CHEBI:567361

subject_name: Cladribine

object_name: multiple sclerosis


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:145421

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:145421

object_name: chronic myelomonocytic leukemia


subject: CHEBI:145421

object_name: Cytopenia


subject: UMLS:C4317276

object_name: Myelodysplasia


subject: UMLS:C4317276


subject: UMLS:C4317276


subject: UMLS:C4317276


subject: UMLS:C4317276


subject: CHEBI:36704

subject_name: Imiquimod

object_name: brain neoplasm


subject: CHEBI:36704

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:36704

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:36704

object_name: anaplastic astrocytoma


subject: CHEBI:36704

object_name: medulloblastoma


subject: CHEBI:36704

object_name: childhood medulloblastoma


subject: CHEBI:36704

object_name: adult medulloblastoma


subject: CHEBI:36704

object_name: glioblastoma


subject: CHEBI:36704

object_name: Childhood Glioblastoma


subject: CHEBI:36704

object_name: adult glioblastoma


subject: CHEBI:36704

object_name: glioma susceptibility 1


subject: CHEBI:36704

object_name: ependymoma


subject: CHEBI:36704

object_name: childhood ependymoma


subject: CHEBI:36704

object_name: Newly Diagnosed Childhood Ependymoma


subject: CHEBI:36704

object_name: Adult Ependymoma


subject: CHEBI:2704

subject_name: Anastrozole

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:2704

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:91951

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:49668

object_name: Carcinoma breast stage IV


subject: CHEBI:49668

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49668

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:87620

subject_name: EPIESTRIOL

object_name: Epistaxis, CTCAE


subject: CHEBI:87620

object_name: Epistaxis


subject: CHEBI:87620

object_name: hereditary hemorrhagic telangiectasia


subject: CHEBI:27974

subject_name: Estriol


subject: CHEBI:27974


subject: CHEBI:27974


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: polyp of large intestine


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: long COVID-19


subject: CHEMBL.COMPOUND:CHEMBL4297785

subject_name: VIBOSTOLIMAB

object_name: lung neoplasm


subject: UMLS:C5432276

subject_name: Vibostolimab


subject: PUBCHEM.COMPOUND:138608760

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:138608760

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:138608760

object_name: Solid Neoplasm


subject: UMLS:C5447308

subject_name: CDK7 Inhibitor LY3405105


subject: UMLS:C5447308


subject: UMLS:C5447308


subject: UMLS:C0359180

subject_name: albumin solution

object_name: secondary edema


subject: CHEBI:232390

object_name: pervasive developmental disorder


subject: CHEBI:232390

object_name: autism


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Urinary tract infections in children


subject: PUBCHEM.COMPOUND:166177189

subject_name: Nerandomilast

object_name: liver failure


subject: CHEBI:50634

object_name: Alkalosis


subject: CHEBI:50634

object_name: Alkalosis, CTCAE


subject: CHEBI:50634

object_name: respiratory failure


subject: CHEBI:50634

object_name: bronchopulmonary dysplasia


subject: CHEBI:50634

object_name: Respiratory insufficiency


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:9605

subject_name: Tirofiban

object_name: acute myocardial infarction


subject: CHEBI:9605

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Presenile dementia


subject: UMLS:C0013227

object_name: dementia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEMBL.COMPOUND:CHEMBL2109121

subject_name: DIPHTHERIA TOXOID

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0012551

subject_name: diphtheria toxoid vaccine, inactivated


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: diabetic kidney disease


subject: UMLS:C1099192


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Allosensitization


subject: CHEBI:61049

object_name: failure; transplant, kidney


subject: CHEBI:9168

subject_name: Sirolimus

object_name: age


subject: UMLS:C0358780

subject_name: Allergen extract vaccine

object_name: Allergy in children


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: HER2 protein overexpression


subject: CHEBI:90001

object_name: HER2 positive breast carcinoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: UNII:GJ0EGN38UL

subject_name: Ibutamoren

object_name: fibromyalgia


subject: UMLS:C0528358


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Clinical infection


subject: PUBCHEM.COMPOUND:147912

object_name: infectious disease


subject: UMLS:C5418142

subject_name: Pyramax

object_name: Malaria, antepartum


subject: CHEBI:119915

subject_name: Fentanyl

object_name: otitis media


subject: CHEBI:119915

object_name: infectious otitis media


subject: CHEBI:119915

object_name: Otitis Media, CTCAE


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:59524

subject_name: lipoarabinomannan

object_name: chronic hepatitis B virus infection


subject: PR:000034444

subject_name: L-lysine 2,3-aminomutase


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Fanconi anemia


subject: CHEBI:125354

object_name: Fanconi anemia complementation group A


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: ataxia telangiectasia


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:8382


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:82354

subject_name: Nitrogen mustard N-oxide

object_name: adult lymphoma


subject: CHEBI:82354

object_name: lymphoma


subject: CHEBI:82354

object_name: pediatric lymphoma


subject: CHEBI:28925

subject_name: Mechlorethamine


subject: CHEBI:28925


subject: CHEBI:28925


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:71417


subject: CHEBI:71417


subject: UMLS:C5203528

subject_name: Magnesium Sulfate Liquid Injection

object_name: Post-Operative Pain


subject: UNII:D07V79Q44T

object_name: non-Hodgkin lymphoma


subject: UMLS:C1566164


subject: CHEBI:9448

subject_name: Terbinafine

object_name: Axial Spondyloarthritis


subject: CHEBI:9448

object_name: Psoriatic arthritis with spine involvement


subject: CHEBI:9448

object_name: ankylosing spondylitis


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: patent ductus arteriosus


subject: CHEBI:85990

subject_name: Panobinostat

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:85990

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C3853898

object_name: colorectal cancer


subject: UMLS:C3853898

object_name: colorectal carcinoma


subject: UMLS:C3853898

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3853898

object_name: carcinoma of esophagus


subject: UMLS:C3853898

object_name: esophageal cancer


subject: UMLS:C3853898

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3853898

object_name: neoplasm of esophagus


subject: UMLS:C3853898

object_name: prostate carcinoma


subject: UMLS:C3853898

object_name: prostate cancer


subject: UMLS:C3853898

object_name: ovarian cancer


subject: UMLS:C3853898

object_name: ovarian neoplasm


subject: UMLS:C3853898

object_name: ovarian carcinoma


subject: UMLS:C3853898

object_name: non-small cell lung carcinoma


subject: UMLS:C3853898

object_name: head and neck cancer


subject: UMLS:C3853898

object_name: Stomach cancer


subject: UMLS:C3853898

object_name: gastric cancer


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:42567

subject_name: Fisetin

object_name: peripheral vascular disease


subject: CHEBI:42567

object_name: peripheral arterial disease


subject: CHEBI:42567

object_name: Ambulation Difficulty


subject: CHEBI:42567

object_name: intermittent vascular claudication


subject: CHEBI:42567

object_name: Claudication


subject: CHEBI:42567

object_name: Antalgic gait


subject: UMLS:C1434448

object_name: glioma


subject: UMLS:C1434448

object_name: malignant glioma


subject: UMLS:C1434448

object_name: Childhood Brain Neoplasm


subject: UMLS:C1434448

object_name: brain cancer


subject: UMLS:C1434448

object_name: brain neoplasm


subject: UMLS:C5555168

subject_name: Nanoparticle SN-38-encapsulated Micelle Formulation SNB-101

object_name: Neck Carcinoma


subject: UMLS:C5555168

object_name: head and neck neoplasm


subject: UMLS:C5555168


subject: UMLS:C5555168

object_name: colorectal cancer


subject: UMLS:C5555168

object_name: colorectal carcinoma


subject: UMLS:C5555168

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5555168

object_name: pancreatic neoplasm


subject: UMLS:C5555168

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5555168

object_name: malignant pancreatic neoplasm


subject: UMLS:C5555168

object_name: Stomach cancer


subject: UMLS:C5555168

object_name: gastric cancer


subject: UMLS:C5555168

object_name: ovarian cancer


subject: UMLS:C5555168

object_name: ovarian neoplasm


subject: UMLS:C5555168

object_name: ovarian carcinoma


subject: UMLS:C5555168

object_name: Childhood Breast Carcinoma


subject: UMLS:C5555168

object_name: breast carcinoma


subject: UMLS:C5555168

object_name: breast cancer


subject: CHEBI:8382

subject_name: Prednisone

object_name: lung cancer


subject: CHEBI:8382

object_name: lung neoplasm


subject: CHEBI:8382

object_name: lung carcinoma


subject: CHEBI:8382

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:8382

object_name: Embolism, Tumor


subject: CHEBI:8382

object_name: Neoplasm Metastasis


subject: UMLS:C5667097

subject_name: RET Inhibitor LOXO-260

object_name: non-small cell lung carcinoma


subject: UMLS:C5667097

object_name: thyroid tumor


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Brain conditions NEC in ICD9CM


subject: CHEBI:47657

object_name: Other conditions of brain


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: blepharitis


subject: CHEBI:63611

object_name: keratitis


subject: CHEBI:63611

object_name: Keratitis, CTCAE


subject: CHEBI:63611

object_name: conjunctivitis


subject: CHEBI:63611

object_name: Conjunctivitis, CTCAE


subject: CHEBI:53612

subject_name: Squaric acid dibutyl ester

object_name: herpes labialis


subject: CHEBI:53612

object_name: herpes simplex


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: lung cancer


subject: PUBCHEM.COMPOUND:43805

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:43805

object_name: lung carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:2K3YP54BYU

subject_name: Retinol acetate

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Photodamaged skin


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C5690388

object_name: Leigh syndrome


subject: MESH:C000721994

subject_name: cysteamine-pantetheine disulfide


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:31355

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85995

subject_name: lenvatinib mesylate

object_name: esophageal squamous cell carcinoma


subject: CHEBI:85995

object_name: esophageal adenocarcinoma


subject: CHEBI:85995


subject: CHEBI:85995

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85995

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85995


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994

object_name: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994


subject: CHEBI:85994

object_name: Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994

object_name: Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:85994

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: PUBCHEM.COMPOUND:11654566

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Indolent lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: B-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: lymphoplasmacytic lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:11654566

object_name: marginal zone lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: MALT lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: acute graft versus host disease


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: GTOPDB:1160

subject_name: hCG


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:5281052

subject_name: Kava

object_name: generalized anxiety disorder


subject: CHEBI:4325

subject_name: Dapsone

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:4325

object_name: subarachnoid hemorrhage


subject: CHEBI:4325

object_name: Cerebral Vasospasm


subject: CHEBI:4325

object_name: Delayed cerebral ischaemia


subject: CHEBI:4325

object_name: brain ischemia


subject: UMLS:C0445115

subject_name: Normal saline

object_name: dengue disease


subject: UMLS:C0445115

object_name: Severe Dengue


subject: CHEBI:64312

subject_name: Memantine

object_name: AIDS dementia


subject: CHEBI:64312

object_name: HIV infection


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: hepatitis


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:9123

subject_name: Sertraline

object_name: intellectual disability


subject: CHEBI:9123

object_name: stereotypic movement disorder


subject: CHEBI:9123

object_name: Self-injurious behavior


subject: CHEBI:41879

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:91872


subject: CHEBI:91872

object_name: acute myeloid leukemia


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:3685

object_name: acute lymphoblastic leukemia


subject: CHEBI:42068

subject_name: Idarubicin


subject: PUBCHEM.COMPOUND:11654566


subject: PUBCHEM.COMPOUND:11654566


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate


subject: CHEBI:135765


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:78543


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E

object_name: phenylketonuria


subject: CHEBI:75929

object_name: treatment resistant depression


subject: CHEBI:75929


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:63925

subject_name: PhXa 85

object_name: drugs; glaucoma


subject: PUBCHEM.COMPOUND:9914270

subject_name: Landiolol

object_name: Low Cardiac Output Syndrome


subject: PUBCHEM.COMPOUND:9914270

object_name: heart failure


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Urothelial carcinoma ureter metastatic


subject: CHEBI:72317

object_name: Metastatic Urethral Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:72317

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: CHEBI:72317

object_name: Advanced Ureter Urothelial Carcinoma


subject: CHEBI:72317

object_name: Advanced Bladder Urothelial Carcinoma


subject: CHEBI:72317

object_name: Advanced Urethral Urothelial Carcinoma


subject: CHEBI:72317

object_name: Stage III Urethral Cancer AJCC v8


subject: CHEBI:72317

object_name: Advanced Renal Pelvis Urothelial Carcinoma


subject: CHEBI:72317

object_name: Stage IV Urethral Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Ureter Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Ureter Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Renal Pelvis Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Renal Pelvis and Ureter Cancer AJCC v8


subject: CHEBI:151315

subject_name: Heparin

object_name: Acute Ischemic Stroke


subject: CHEBI:151315

object_name: Ischemic stroke


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: coronary atherosclerosis


subject: CHEBI:478164

subject_name: Cefepime

object_name: pneumonia


subject: CHEBI:478164

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: UNII:9GG866ZP1E

subject_name: SIBUTRAMINE HYDROCHLORIDE

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:9GG866ZP1E

object_name: obesity


subject: UNII:9GG866ZP1E

object_name: Obesity, CTCAE


subject: UNII:OGM0YHD1WF

subject_name: Meridia


subject: UNII:OGM0YHD1WF


subject: UNII:OGM0YHD1WF


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: head and neck squamous cell carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: GTOPDB:10236

subject_name: volociximab

object_name: pancreatic neoplasm


subject: GTOPDB:10236

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:10236

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: biliary tract cancer


subject: GTOPDB:13085

object_name: liver carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C5706540

subject_name: Anti-CTLA-4 Monoclonal Antibody SHR-8068


subject: UMLS:C5706540


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Wilson disease


subject: CHEBI:85155

subject_name: Netupitant

object_name: endometrial cancer


subject: CHEBI:85155

object_name: uterine corpus cancer


subject: CHEBI:85155

object_name: endometrial carcinoma


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UNII:YZS3R7LP44


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Coronavinae infectious disease


subject: CHEBI:9241

object_name: viral pneumonia


subject: UMLS:C1831728

subject_name: recombinant interferon alpha-1b

object_name: renal carcinoma


subject: UMLS:C1831728

object_name: kidney neoplasm


subject: UMLS:C1831728

object_name: kidney cancer


subject: UMLS:C4733594

object_name: sickle cell disease


subject: UMLS:C4043264

object_name: malaria


subject: CHEBI:63450

subject_name: Masitinib

object_name: Alzheimer disease type 1


subject: CHEBI:63450

object_name: Alzheimer disease


subject: CHEBI:30742

subject_name: macrogol

object_name: Injury of other nerves at wrist and hand level of unspecified arm, initial encounter


subject: UNII:2VU8WT49WX

subject_name: THROMBOMODULIN ALFA

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:77572

subject_name: Tranilast

object_name: nasopharyngeal carcinoma


subject: CHEBI:77572

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:77572

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:77572

object_name: Recurrent Carcinoma


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: mucositis


subject: CHEBI:63115

subject_name: Fingolimod

object_name: stroke disorder


subject: CHEBI:63115

object_name: cerebrovascular disorder


subject: CHEBI:63115

object_name: Stroke (heart beat)


subject: CHEBI:63115

object_name: Stroke, CTCAE


subject: UNII:7UP768IP4M

object_name: Acute migraine


subject: UMLS:C5139837

subject_name: Pegadricase

object_name: gout


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Wound dehiscence


subject: CHEBI:51254

object_name: Wound Dehiscence, CTCAE


subject: CHEBI:51254

object_name: Infection of musculoskeletal system


subject: CHEBI:51254

object_name: Traumatic lesion during delivery


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: non-small cell squamous lung carcinoma


subject: UNII:QEA2EG9S3E

subject_name: PUMITAMIG

object_name: non-small cell lung carcinoma


subject: CHEBI:32599

object_name: dyskinesia of esophagus


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0379528

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0379528

object_name: metastatic melanoma


subject: UMLS:C0379528

object_name: Melanoma recurrent


subject: UMLS:C0379528

object_name: nodular malignant melanoma


subject: UMLS:C0379528

object_name: lentigo maligna melanoma


subject: UMLS:C0379528

object_name: superficial spreading melanoma


subject: UMLS:C0379528

object_name: acral lentiginous melanoma


subject: UMLS:C0379528

object_name: Solar Radiation-Related Cutaneous Melanoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: head and neck squamous cell carcinoma


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Adult growth hormone deficiency


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Mycoplasma pneumoniae pneumonia


subject: CHEBI:48923

subject_name: erythromycin

object_name: kidney failure


subject: CHEBI:42355

subject_name: Erythromycin


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Metastatic non-small cell lung cancer


subject: UNII:GKF8S4C432

object_name: Non-small cell lung cancer stage IIIB


subject: GTOPDB:12966

subject_name: cadonilimab


subject: GTOPDB:12966


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Upper Respiratory Infections


subject: CHEBI:46195

object_name: respiratory tract infectious disorder


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:5551

subject_name: Guaifenesin


subject: CHEBI:5551


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine

object_name: ventilator-associated pneumonia


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE


subject: GTOPDB:7055

subject_name: sucralfate


subject: CHEBI:50730

subject_name: Montelukast

object_name: Persistent asthma


subject: UNII:8CXV4OU367

subject_name: Arbidol

object_name: Atopic rhinitis


subject: UNII:8CXV4OU367

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:134730

subject_name: Umifenovir


subject: CHEBI:134730


subject: UMLS:C5399815


subject: UMLS:C5399815


subject: CHEBI:94647

subject_name: Tropisetron

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:94647

object_name: colorectal cancer


subject: CHEBI:94647

object_name: colorectal carcinoma


subject: CHEBI:94647

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:32269


subject: CHEBI:32269


subject: CHEBI:32269


subject: CHEBI:32269


subject: CHEMBL.COMPOUND:CHEMBL4650509

subject_name: MIBAVADEMAB

object_name: FHA (functional hypothalamic amenorrhea)


subject: UMLS:C5449393

subject_name: Mibavademab


subject: CHEBI:231614

subject_name: Nivolumab

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:231614

object_name: acute myeloid leukemia


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:6DXN080KGB

subject_name: FRESPACIGUAT

object_name: Hypoxemia


subject: UNII:6DXN080KGB

object_name: Blood oxygen concentration below reference range (finding)


subject: UNII:6DXN080KGB

object_name: pneumonia


subject: UNII:6DXN080KGB

object_name: COVID-19-Associated Pneumonia


subject: UNII:6DXN080KGB


subject: DRUGBANK:DB16471

object_name: myelofibrosis


subject: DRUGBANK:DB16471


subject: DRUGBANK:DB16471

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:XN7HA74WB0

object_name: Kinetic tremor


subject: UMLS:C3554960

subject_name: DHEA Tablet

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C3554960

object_name: pulmonary hypertension


subject: UMLS:C3554960

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C3554960

object_name: pulmonary arterial hypertension


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: diabetes mellitus


subject: MESH:D000077203

object_name: coronary artery disorder


subject: MESH:D000077203

object_name: coronary atherosclerosis


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UMLS:C3542461


subject: CHEBI:404903

subject_name: Ertapenem

object_name: endometritis


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: leukemia


subject: UNII:M487QF2F4V

object_name: childhood leukemia


subject: UNII:M487QF2F4V

object_name: Myelodysplasia


subject: UNII:M487QF2F4V

object_name: leukopenia


subject: UNII:M487QF2F4V

object_name: neutropenia


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171

object_name: Drug toxicity


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Drug action (disorder)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: eosinophilic gastroenteritis


subject: UNII:71492GE1FX

object_name: eosinophilic gastritis


subject: UNII:3X48A86C8K

subject_name: polysaccharide-K

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:3X48A86C8K

object_name: Carcinoma breast stage IV


subject: UNII:3X48A86C8K

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:3X48A86C8K

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:3X48A86C8K

object_name: HER2 positive


subject: UNII:3X48A86C8K

object_name: Breast cancer recurrent


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Meniere disease


subject: CHEBI:176381

subject_name: Diosmin

object_name: Menorrhagia


subject: CHEBI:176381

object_name: Menorrhagia, CTCAE


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: B-Cell Leukemia


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: leukemia


subject: UMLS:C0699319

object_name: childhood leukemia


subject: UMLS:C0699319

object_name: chronic leukemia


subject: UMLS:C0699319

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0699319


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: Harmful pattern of substance use


subject: CHEBI:16581

object_name: substance abuse


subject: CHEBI:5163

subject_name: fosinopril

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: Shock


subject: PUBCHEM.COMPOUND:53477739

object_name: central diabetes insipidus


subject: PUBCHEM.COMPOUND:53477739

object_name: neurohypophyseal diabetes insipidus


subject: PUBCHEM.COMPOUND:53477739

object_name: Vasopressin causing adverse effects in therapeutic use


subject: PUBCHEM.COMPOUND:53477739

object_name: Vasopressor adverse reaction


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C5966161


subject: UMLS:C4305963

object_name: stroke disorder


subject: UMLS:C4305963

object_name: cerebrovascular disorder


subject: UMLS:C4305963

object_name: Stroke (heart beat)


subject: UMLS:C4305963

object_name: Stroke, CTCAE


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: liver carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UMLS:C2346810

object_name: Carcinoma breast stage IV


subject: UNII:18EAY4870E

subject_name: MIPOMERSEN SODIUM

object_name: Familial hypercholesterolemia - heterozygous


subject: UNII:18EAY4870E

object_name: coronary artery disorder


subject: UNII:18EAY4870E

object_name: coronary atherosclerosis


subject: UNII:9GJ8S4GU0M

subject_name: Mipomersen


subject: UNII:9GJ8S4GU0M


subject: UNII:9GJ8S4GU0M


subject: CHEBI:30746

subject_name: Benzoic acid

object_name: urea cycle disorder


subject: CHEBI:41500

subject_name: Phenylbutyrates


subject: UMLS:C0456388

subject_name: Blood product

object_name: Intraoperative Hemorrhage


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: cesarean section; dehiscence


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: UMLS:C3535645

subject_name: THIOCTIC ACID, (+)-


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: influenza


subject: UMLS:C4684972

subject_name: Microtubule Inhibitor SCB01A

object_name: Malignant Solid Neoplasm


subject: UMLS:C2095775

subject_name: ampicillins

object_name: Extreme immaturity


subject: UMLS:C2095775

object_name: Neonatal necrotizing enterocolitis


subject: UMLS:C2095775

object_name: Neonatal Late-Onset Sepsis


subject: UMLS:C2095775

object_name: Neonatal Early-Onset Sepsis


subject: UMLS:C2095775

object_name: infectious disease


subject: UMLS:C2095775

object_name: Neonatal death


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Myocardial fibrosis


subject: CHEBI:85078

object_name: myocarditis


subject: UNII:CS4U38E731

subject_name: Nigella sativa oil

object_name: oral submucous fibrosis


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: IgA Nephropathy


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: osteoarthritis of both knees


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C532412


subject: UMLS:C5888788

subject_name: Cytarabine Liquid Injection

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5888788

object_name: acute myeloid leukemia


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: pancreatic neoplasm


subject: CHEBI:135947

object_name: exocrine pancreatic carcinoma


subject: CHEBI:135947

object_name: malignant pancreatic neoplasm


subject: UMLS:C2743193

object_name: psoriasis


subject: CHEBI:134677

subject_name: Crisaborole


subject: PUBCHEM.COMPOUND:121595900

subject_name: Ilaprazole sodium

object_name: Stress ulcer haemorrhage


subject: UNII:T8KRT8S6GR

subject_name: ILAPRAZOLE SODIUM


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: hypertriglyceridemia


subject: UNII:2O4BE0K238

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Cisplatin adverse reaction


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Coronary microvascular dysfunction


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:135962

subject_name: Dapoxetine

object_name: physiological sexual disorder


subject: PUBCHEM.COMPOUND:6093437


subject: UNII:93NS566KF7

subject_name: GEMTUZUMAB

object_name: acute myeloid leukemia with minimal differentiation


subject: UNII:93NS566KF7


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab


subject: UMLS:C0872968

subject_name: gemtuzumab


subject: UMLS:C0872968


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Metastatic Breast Carcinoma


subject: CHEBI:52717

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:52717

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:52717

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:77590

subject_name: Armodafinil

object_name: Hypopnea


subject: CHEBI:60799

subject_name: Esketamine

object_name: Postoperative Pain, Chronic


subject: UMLS:C3252350

object_name: head and neck squamous cell carcinoma


subject: CHEBI:229764

subject_name: Selinexor

object_name: nephroblastoma


subject: CHEBI:229764

object_name: Wilms tumor


subject: CHEBI:229764

object_name: childhood kidney Wilms tumor


subject: CHEBI:229764

object_name: rhabdoid tumor


subject: CHEBI:229764

object_name: XPO1 Gene Mutation


subject: CHEBI:229764

object_name: Wilms tumor 1


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: Stage II Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135659064

object_name: Stage II Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:135659064

object_name: Stage II Colon Cancer


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: PUBCHEM.COMPOUND:71301229


subject: PUBCHEM.COMPOUND:71301229


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:15367

subject_name: Tretinoin

object_name: acne


subject: CHEBI:50648

subject_name: Alitretinoin


subject: UNII:KJ7XLN1TIR

object_name: Drug-Induced Ototoxicity


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: Deep vein thrombosis of lower limb


subject: UNII:7UQ7X4Y489

object_name: Inflammatory Response


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: age-related macular degeneration


subject: CHEBI:135919

subject_name: Nesiritide

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Stage I Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6096882

object_name: Stage I Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Renal cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:6096882

object_name: Renal cancer recurrent


subject: PUBCHEM.COMPOUND:6096882

object_name: Stage II Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6096882

object_name: Stage II Renal Cell Cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: Stage II Renal Cell Cancer AJCC v7


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Postoperative Complications


subject: CHEBI:4910

subject_name: Etomidate


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:9667

object_name: Back pain


subject: CHEBI:9667

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:6121

subject_name: Ketamine

object_name: somatoform disorder


subject: CHEBI:6121

object_name: dissociative disorder


subject: UNII:XX8E5WP7FS

object_name: osteoarthritis


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: marginal zone lymphoma


subject: CHEBI:91397

object_name: MALT lymphoma


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: UMLS:C2348637


subject: UMLS:C2348637

object_name: mantle cell lymphoma


subject: UMLS:C2348637

object_name: grade 3A follicular lymphoma


subject: UMLS:C2348637

object_name: Follicular lymphoma refractory


subject: UMLS:C2348637

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UMLS:C2348637

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UMLS:C2348637

object_name: Follicular lymphoma recurrent


subject: UNII:0IN1TZ844E

subject_name: ZELENECTIDE PEVEDOTIN

object_name: Childhood Breast Carcinoma


subject: UNII:0IN1TZ844E

object_name: breast carcinoma


subject: UNII:0IN1TZ844E

object_name: breast cancer


subject: UMLS:C5555005

subject_name: Zelenectide Pevedotin


subject: UMLS:C5555005


subject: UMLS:C5555005


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:94518

object_name: acute myeloid leukemia


subject: CHEBI:94518

object_name: Myelodysplasia


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: Hereditary Angioedema Types I and II


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: UMLS:C1614968

subject_name: Sativex

object_name: diabetic neuropathy


subject: CHEBI:62855

subject_name: beta-elemene

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:62855

object_name: anaplastic oligoastrocytoma


subject: CHEBI:62855

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:62855

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:62855

object_name: anaplastic astrocytoma


subject: CHEBI:62855

object_name: glioblastoma


subject: CHEBI:62855

object_name: Childhood Glioblastoma


subject: CHEBI:62855

object_name: adult glioblastoma


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: HER2 positive breast carcinoma


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UMLS:C4331966


subject: UMLS:C1704241

subject_name: complex (molecular entity)

object_name: hypotrichosis


subject: UMLS:C1704241

object_name: alopecia


subject: CHEBI:57586

subject_name: biotinate


subject: CHEBI:57586


subject: CHEBI:15956

subject_name: Biotin


subject: CHEBI:15956


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen


subject: PUBCHEM.COMPOUND:133604


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C0010803

subject_name: Cytokeratin


subject: UMLS:C0010803


subject: UMLS:C0022564

subject_name: Keratin


subject: UMLS:C0022564


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: AL amyloidosis


subject: CHEBI:71419

subject_name: phenazopyridine hydrochloride

object_name: urinary tract infection


subject: CHEBI:71419

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:135580740

subject_name: Phenazo


subject: PUBCHEM.COMPOUND:135580740


subject: UNII:K2J09EMJ52

subject_name: Phenazopyridine


subject: UNII:K2J09EMJ52


subject: CHEBI:233324

subject_name: Darovasertib

object_name: uveal melanoma


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone


subject: UNII:788PET5SUA

subject_name: Basmisanil

object_name: Dup15q syndrome


subject: CHEBI:81569

subject_name: Follitropin

object_name: female infertility


subject: UMLS:C0083246


subject: PUBCHEM.COMPOUND:11525088

subject_name: Elesclomol sodium

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:11525088

object_name: acute myeloid leukemia


subject: UNII:L219C7807V

subject_name: ELESCLOMOL SODIUM


subject: UNII:L219C7807V


subject: UMLS:C2699865

subject_name: Elesclomol Sodium


subject: UMLS:C2699865


subject: CHEBI:110423

subject_name: Clodronic acid

object_name: Radiation induced brachial plexopathy


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: PUBCHEM.COMPOUND:11305985

subject_name: TOCOPHEROL ACETATE


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate


subject: CHEBI:230570


subject: CHEBI:18145

subject_name: Vitamin E


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Refractory Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397


subject: CHEBI:91397

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:50858

subject_name: corticosteroid

object_name: osteoporosis risk


subject: CHEBI:50858

object_name: Osteopenia/osteoporosis


subject: CHEBI:50858

object_name: Osteopenia


subject: CHEBI:50858

object_name: Osteoporotic Fractures


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]

object_name: asthma


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: central retinal vein occlusion


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: non-Hodgkin lymphoma


subject: UMLS:C4331803

object_name: T-cell prolymphocytic leukemia


subject: UMLS:C4744685


subject: UMLS:C4744685


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: psychosis


subject: PUBCHEM.COMPOUND:6918224

object_name: Nonorganic psychosis


subject: PUBCHEM.COMPOUND:6918224

object_name: Psychosis, CTCAE


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:8707


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Postoperative hematoma


subject: CHEBI:135552

subject_name: Prucalopride

object_name: dyspepsia


subject: CHEBI:135552

object_name: Dyspepsia, CTCAE


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: carpal tunnel syndrome 1


subject: CHEBI:144903

object_name: carpal tunnel syndrome


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: UMLS:C4086994

object_name: Human Papilloma Virus, Female


subject: UMLS:C4086994

object_name: Human Papilloma Virus, Male


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:4026

object_name: Blast Phase


subject: CHEBI:4026

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: juvenile myelomonocytic leukemia


subject: UNII:PVI5M0M1GW

object_name: chronic myelomonocytic leukemia


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Malignant myeloproliferative neoplasm


subject: UNII:PVI5M0M1GW

object_name: lymphoblastic lymphoma


subject: UNII:PVI5M0M1GW

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Lymphoblastic Lymphoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: Plasma cell myeloma recurrent


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: myeloproliferative neoplasm


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:4F4X42SYQ6

object_name: aplastic anemia


subject: UNII:4F4X42SYQ6

object_name: idiopathic aplastic anemia


subject: UMLS:C0295415

subject_name: rituximab

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C0295415

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C0295415

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0295415

object_name: chronic myelomonocytic leukemia


subject: UMLS:C0295415

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0295415

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C0295415


subject: UMLS:C0295415

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C0295415


subject: UMLS:C0295415

object_name: lymphoblastic lymphoma


subject: UMLS:C0295415

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C0295415

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C1828559

subject_name: GARCINIA MANGOSTANA Preparation

object_name: Generalized chronic periodontitis


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: rubeosis iridis


subject: UNII:15C2VL427D

object_name: glaucoma


subject: UNII:15C2VL427D

object_name: Glaucoma, CTCAE


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: PUBCHEM.COMPOUND:3417

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:3417

object_name: cystitis


subject: PUBCHEM.COMPOUND:3417

object_name: Cystitis, CTCAE


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:28915


subject: UNII:1RXS4UE564

subject_name: Alteplase

object_name: intracerebral hemorrhage


subject: UMLS:C5964774

subject_name: Oncolytic Adenovirus Ad5-DNX-2401

object_name: Adult Gliosarcoma


subject: UMLS:C5964774

object_name: gliosarcoma


subject: UMLS:C5964774

object_name: Childhood Gliosarcoma


subject: UMLS:C5964774

object_name: brain cancer


subject: UMLS:C5964774

object_name: glioblastoma


subject: UMLS:C5964774

object_name: Childhood Glioblastoma


subject: UMLS:C5964774

object_name: adult glioblastoma


subject: UMLS:C5964774

object_name: brain neoplasm


subject: UMLS:C5964774

object_name: nervous system disorder


subject: UMLS:C5964774

object_name: Childhood Brain Neoplasm


subject: UMLS:C5964774

object_name: primitive neuroectodermal tumor


subject: UMLS:C5964774

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C5964774

object_name: neuroepithelial neoplasm


subject: UMLS:C5964774

object_name: nervous system cancer


subject: UMLS:C5964774

object_name: glioma


subject: UMLS:C5964774

object_name: malignant glioma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: DRUGBANK:DB18014

object_name: Invasive fungal infection


subject: UMLS:C3896694

subject_name: MAGE-A3-expressing Adenovirus Type 5 Vaccine

object_name: non-small cell lung carcinoma


subject: CHEBI:82960

subject_name: Raltegravir

object_name: chronic kidney disease


subject: CHEBI:82960

object_name: Chronic uremia


subject: UMLS:C1726029

subject_name: Advair HFA

object_name: altitude oedema